These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 15107657)
1. Do equivalent doses of escitalopram and citalopram have similar efficacy? A pooled analysis of two positive placebo-controlled studies in major depressive disorder. Lepola U; Wade A; Andersen HF Int Clin Psychopharmacol; 2004 May; 19(3):149-55. PubMed ID: 15107657 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients. Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074 [TBL] [Abstract][Full Text] [Related]
3. Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder. Khan A; Bose A; Alexopoulos GS; Gommoll C; Li D; Gandhi C Clin Drug Investig; 2007; 27(7):481-92. PubMed ID: 17563128 [TBL] [Abstract][Full Text] [Related]
4. [Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder]. Azorin JM; Llorca PM; Despiegel N; Verpillat P Encephale; 2004; 30(2):158-66. PubMed ID: 15107719 [TBL] [Abstract][Full Text] [Related]
5. Escitalopram (S-enantiomer of citalopram): clinical efficacy and onset of action predicted from a rat model. Montgomery SA; Loft H; Sánchez C; Reines EH; Papp M Pharmacol Toxicol; 2001 May; 88(5):282-6. PubMed ID: 11393591 [TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, 24-week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorder. Colonna L; Andersen HF; Reines EH Curr Med Res Opin; 2005 Oct; 21(10):1659-68. PubMed ID: 16238906 [TBL] [Abstract][Full Text] [Related]
7. A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients. Boulenger JP; Huusom AK; Florea I; Baekdal T; Sarchiapone M Curr Med Res Opin; 2006 Jul; 22(7):1331-41. PubMed ID: 16834832 [TBL] [Abstract][Full Text] [Related]
8. Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care. Lepola UM; Loft H; Reines EH Int Clin Psychopharmacol; 2003 Jul; 18(4):211-7. PubMed ID: 12817155 [TBL] [Abstract][Full Text] [Related]
9. Effective dose of escitalopram in moderate versus severe DSM-IV major depression. Bech P; Andersen HF; Wade A Pharmacopsychiatry; 2006 Jul; 39(4):128-34. PubMed ID: 16871468 [TBL] [Abstract][Full Text] [Related]
10. Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder. Moore N; Verdoux H; Fantino B Int Clin Psychopharmacol; 2005 May; 20(3):131-7. PubMed ID: 15812262 [TBL] [Abstract][Full Text] [Related]
11. Combining escitalopram with gaboxadol provides no additional benefit in the treatment of patients with severe major depressive disorder. Kasper S; Ebert B; Larsen K; Tonnoir B Int J Neuropsychopharmacol; 2012 Jul; 15(6):715-25. PubMed ID: 22008735 [TBL] [Abstract][Full Text] [Related]
12. Escitalopram in the treatment of adolescent depression: a randomized, double-blind, placebo-controlled extension trial. Findling RL; Robb A; Bose A J Child Adolesc Psychopharmacol; 2013 Sep; 23(7):468-80. PubMed ID: 24041408 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, randomized, double-blind, flexible-dose study. Ou JJ; Xun GL; Wu RR; Li LH; Fang MS; Zhang HG; Xie SP; Shi JG; Du B; Yuan XQ; Zhao JP Psychopharmacology (Berl); 2011 Feb; 213(2-3):639-46. PubMed ID: 20340011 [TBL] [Abstract][Full Text] [Related]
14. Citalopram and escitalopram in the treatment of major depressive disorder: a pooled analysis of 3 clinical trials. Li H; Li T; Li G; Luo J Ann Clin Psychiatry; 2014 Nov; 26(4):281-7. PubMed ID: 25401715 [TBL] [Abstract][Full Text] [Related]
15. The effect of escitalopram on sleep problems in depressed patients. Lader M; Andersen HF; Baekdal T Hum Psychopharmacol; 2005 Jul; 20(5):349-54. PubMed ID: 15912558 [TBL] [Abstract][Full Text] [Related]
16. Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder. Bose A; Korotzer A; Gommoll C; Li D Depress Anxiety; 2008; 25(10):854-61. PubMed ID: 18050245 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of escitalopram in patients with severe depression: a pooled analysis. Llorca PM; Azorin JM; Despiegel N; Verpillat P Int J Clin Pract; 2005 Mar; 59(3):268-75. PubMed ID: 15857321 [TBL] [Abstract][Full Text] [Related]
18. Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study. Hu YD; Xiang YT; Fang JX; Zu S; Sha S; Shi H; Ungvari GS; Correll CU; Chiu HF; Xue Y; Tian TF; Wu AS; Ma X; Wang G Psychol Med; 2016 Feb; 46(3):623-35. PubMed ID: 26478208 [TBL] [Abstract][Full Text] [Related]
19. Escitalopram : a review of its use in the management of major depressive and anxiety disorders. Waugh J; Goa KL CNS Drugs; 2003; 17(5):343-62. PubMed ID: 12665392 [TBL] [Abstract][Full Text] [Related]
20. Escitalopram in the treatment of major depressive disorder in primary-care settings: an open-label trial. Chokka P; Legault M Depress Anxiety; 2008; 25(12):E173-81. PubMed ID: 19006260 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]